Nimustine hydrochloride
Indication
Relieve the subjective symptoms and signs of the following diseases: brain and neck cancer, brain tumors, lung cancer, digestive tract cancer (gastric cancer, colon/rectum cancer, esophageal cancer), malignant lymphoma and leukemia, etc.
Manufacturer
Shandong Ruiying Pioneer Pharmaceutical Co., Ltd.
-
Founded in:
2010-03-22 -
Address:
No. 1777 Kunming Road, Heze City, Shandong Province -
Tax NO.:
91371700552233224G -
Registered Funds:
400 million yuan -
Website:
-
Email: